. Author manuscript; available in PMC: 2011 May 26.

Published in final edited form as: Cleve Clin J Med. 2010 Jul;77(7):468–476. doi: 10.3949/ccjm.77a.09135

TABLE 2.

Antidiabetic effects of bariatric procedures

	LAPAROSCOPIC ADJUSTABLE GASTRIC BANDING	ROUX-EN-Y GASTRIC BYPASS	BILIOPANCREATIC DIVERSION
Tempo of diabetes remission	Slow	Rapid	Rapid
Insulin sensitivity	Improved	Improved	Supranormal
Insulin secretion	Reduced	Increased	Reduced
Glucagon-like peptide-1 levels	No change	Increased	Increased
Peptide YY levels	No change	Increased	Increased
Glucose-dependent insulinotropic peptide levels	No change	No change or increased	Reduced

ADAPTED FROM MINGRONE G. ROLE OF THE INCRETIN SYSTEM IN THE REMISSION OF TYPE 2 DIABETES FOLLOWING BARIATRIC SURGERY. NUTR METAB CARDIOVASC DIS 2008; 18:574–579, WITH PERMISSION FROM ELSEVIER; HTTP://WWW.SCIENCEDIRECT.COM/SCIENCE/JOURNAL/09394753.